Metabolomics Market by Product (GC,UPLC, CE, Surface based Mass Analysis), Application (Biomarker Discovery, Drug Discovery,Functional Genomics), Indication (Cardiology, Oncology,Inborn Errors), End User (Academic Institute,CROs) - Global Forecast to 2025
The global metabolomics market size is projected to reach USD 4.1 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 13.4% during the forecast period. The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, growing demand for personalized medicine and increasing use of metabolomics in toxicology testing are driving the growth of the global metabolomics industry. However, issues related to data examination & data processing in metabolomics and the high cost of tools and instruments are likely to restrain the market growth to a certain extent.
“By Product & Service, the metabolomics instrument accounted for the largest share of the metabolomics market.”
The metabolomics instrument segment is expected to account for the largest market share in 2020. Factors such as the technological advancements in analytical instruments in terms of miniaturization, automation, and computerization; increase in the number of research-related activities worldwide in the field of medicine, nutraceuticals, and metabolomics; and strengthening healthcare infrastructure in developing nations for efficient disease diagnosis and treatment are expected to propel the growth of this segment during the forecast period
“By application, the biomarker discovery segment accounted for the largest share of the metabolomics market.”
The biomarker discovery segment is expected to account for the largest market share in 2020. The use of metabolic biomarkers to assess the pathophysiological health status of patients is increasing. In recent years, as a result of significant technological advancements, metabolomics has become a vital tool in discovering biomarkers.
“By Indication, Cancer segment expected to grow at the fastest growth rate during the forecast period.”
Based on indication, the metabolomics market has been segmented into into cancer, cardiovascular disorders, neurological disorders, metabolic disorders, inborn errors of metabolism, and other indications (respiratory and infectious diseases. The cancer segment is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the increasing number of patients who have cancer and the subsequent increase in the demand for cancer therapies.
“By End user, Academic and Research Institutes accounted for the largest share of the metabolomics market”
The academic and research institutes segment accounted for the largest share of the metabolomics market in 2020. The increasing number of research activities in the field of metabolomics and funding to the academic and research institutes to conduct metabolomics research are the factors responsible for the largest share of the segment.
“Asia Pacific: The fastest-growing region in the metabolomics market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their drug discovery R&D operations and manufacturing to the region. A large number of qualified researchers and low-cost operations in APAC countries, such as India and China, are some of the major factors supporting this trend.
“North America: The largest share of the metabolomics market.”
North America, which includes the US and Canada, accounted for the largest share of the metabolomics market. The large share of the North America region can be attributed to the presence of major players operating in the metabolomics market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
Research Coverage:
The report segments the metabolomics market based on region (North America, Asia Pacific, Europe, Latin America and Middle East & Africa), product & service (metabolomics instruments ((separation tools (((gas chromatography, high-performance liquid chromatography, ultra-performance liquid chromatography, and capillary electrophoresis))), detection tools (((nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and surface-based mass analysis))), bioinformatics tools and services) application (biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications), indication (cancer, cardiovascular disorders, neurological disorders, metabolic disorders, inborn errors of metabolism, and other indications),end user(academic and research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users). Company type (Tier 1, tier 2, Tier 3 providers of metabolomics instruments and services). The report also provides a comprehensive review of market drivers, challenges, and opportunities in the metabolomics market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the metabolomics market and provides them information on key market drivers, challenges, and opportunities.
“By Product & Service, the metabolomics instrument accounted for the largest share of the metabolomics market.”
The metabolomics instrument segment is expected to account for the largest market share in 2020. Factors such as the technological advancements in analytical instruments in terms of miniaturization, automation, and computerization; increase in the number of research-related activities worldwide in the field of medicine, nutraceuticals, and metabolomics; and strengthening healthcare infrastructure in developing nations for efficient disease diagnosis and treatment are expected to propel the growth of this segment during the forecast period
“By application, the biomarker discovery segment accounted for the largest share of the metabolomics market.”
The biomarker discovery segment is expected to account for the largest market share in 2020. The use of metabolic biomarkers to assess the pathophysiological health status of patients is increasing. In recent years, as a result of significant technological advancements, metabolomics has become a vital tool in discovering biomarkers.
“By Indication, Cancer segment expected to grow at the fastest growth rate during the forecast period.”
Based on indication, the metabolomics market has been segmented into into cancer, cardiovascular disorders, neurological disorders, metabolic disorders, inborn errors of metabolism, and other indications (respiratory and infectious diseases. The cancer segment is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the increasing number of patients who have cancer and the subsequent increase in the demand for cancer therapies.
“By End user, Academic and Research Institutes accounted for the largest share of the metabolomics market”
The academic and research institutes segment accounted for the largest share of the metabolomics market in 2020. The increasing number of research activities in the field of metabolomics and funding to the academic and research institutes to conduct metabolomics research are the factors responsible for the largest share of the segment.
“Asia Pacific: The fastest-growing region in the metabolomics market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their drug discovery R&D operations and manufacturing to the region. A large number of qualified researchers and low-cost operations in APAC countries, such as India and China, are some of the major factors supporting this trend.
“North America: The largest share of the metabolomics market.”
North America, which includes the US and Canada, accounted for the largest share of the metabolomics market. The large share of the North America region can be attributed to the presence of major players operating in the metabolomics market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
- By Respondent– Supply Side- 80%, Demand Side-20%
- By Designation— Executives- 25%, CXOs- 20%, Managers - 55%
- By Region— North America - 50%, Europe - 20%, APAC – 20%, RoW- 10%
Research Coverage:
The report segments the metabolomics market based on region (North America, Asia Pacific, Europe, Latin America and Middle East & Africa), product & service (metabolomics instruments ((separation tools (((gas chromatography, high-performance liquid chromatography, ultra-performance liquid chromatography, and capillary electrophoresis))), detection tools (((nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and surface-based mass analysis))), bioinformatics tools and services) application (biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications), indication (cancer, cardiovascular disorders, neurological disorders, metabolic disorders, inborn errors of metabolism, and other indications),end user(academic and research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users). Company type (Tier 1, tier 2, Tier 3 providers of metabolomics instruments and services). The report also provides a comprehensive review of market drivers, challenges, and opportunities in the metabolomics market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the metabolomics market and provides them information on key market drivers, challenges, and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 GLOBAL METABOLOMICS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: METABOLOMICS MARKET
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
2.1.4 DATA TRIANGULATION
FIGURE 3 DATA TRIANGULATION METHODOLOGY
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
FIGURE 5 METABOLOMICS MARKET SIZE (USD MILLION)
FIGURE 6 METABOLOMICS MARKET: GROWTH RATE OF TOP COMPANIES (2018?2019)
FIGURE 7 METABOLOMICS MARKET: FINAL CAGR PROJECTIONS (2020?2025)
FIGURE 8 METABOLOMICS MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
2.3 INDUSTRY INSIGHTS
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 9 METABOLOMICS MARKET SHARE, BY PRODUCT & SERVICE, 2019 VS. 2025 (USD MILLION)
FIGURE 10 METABOLOMICS MARKET SHARE, BY APPLICATION, 2019
FIGURE 11 METABOLOMICS MARKET SIZE, BY INDICATION, 2020 VS. 2025
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE METABOLOMICS MARKET
4 PREMIUM INSIGHTS
4.1 METABOLOMICS MARKET OVERVIEW
FIGURE 13 INCREASING PHARMACEUTICALS R&D ACTIVITIES AND GROWING DEMAND FOR PERSONALIZED MEDICINE WILL FAVOR MARKET GROWTH
4.2 ASIA PACIFIC: METABOLOMICS MARKET SHARE, BY PRODUCT AND SERVICE AND BY COUNTRY (2019)
FIGURE 14 METABOLOMICS INSTRUMENTS SEGMENT ACCOUNTED FOR LARGER SHARE OF ASIA PACIFIC MARKET IN 2019
4.3 METABOLOMICS MARKET SIZE, BY DETECTION TOOLS
FIGURE 15 MASS SPECTROMETRY (MS) SEGMENT WILL CONTINUE TO DOMINATE THE MARKET
4.4 METABOLOMICS MARKET SHARE, BY SEPARATION TOOLS, 2020 VS. 2025
FIGURE 16 HPLC HOLDS THE LARGEST SHARE OF THE MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 METABOLOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 KEY MARKET DRIVERS
5.2.1.1 Availability of government and private funding for metabolomics research
5.2.1.2 Increasing pharmaceutical and biotech R&D expenditure
5.2.1.3 Growing demand for personalized medicine
5.2.2 KEY MARKET RESTRAINTS
5.2.2.1 Issues related to data examination and processing
5.2.2.2 High cost of tools and instruments
5.2.3 KEY MARKET OPPORTUNITIES
5.2.3.1 Biomarker development
5.2.3.2 Lucrative opportunities in emerging markets
5.2.4 KEY MARKET CHALLENGES
5.2.4.1 Complexity and diversity of biological samples
5.2.4.2 Dearth of skilled researchers
5.3 IMPACT OF COVID-19 ON GROWTH OF METABOLOMICS MARKET
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES
6.2.2 TIE-UPS BETWEEN INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS
6.3 REGULATORY ANALYSIS
TABLE 1 REGULATORY STANDARD/APPROVAL REQUIRED FOR METABOLOMICS PRODUCTS, BY COUNTRY/REGION
7 TECHNOLOGY INVESTMENT POTENTIAL
7.1 INTRODUCTION
7.2 INVESTMENT CLIENT NETWORKS
7.3 FUNDING BODIES/INITIATIVES
7.4 ANALYSIS OF POTENTIAL AREAS FOR TECHNOLOGY INVESTMENT USING STRATEGIC EVALUATION
7.4.1 PARAMETERS CONSIDERED FOR EMERGING OPPORTUNITY EVALUATION
7.4.1.1 Level of attractiveness
7.4.1.2 Probability of success
7.4.2 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS
7.4.3 DESCRIPTION OF OPPORTUNITIES
7.4.3.1 Viable (Quadrant 1) – Biomarker discovery and lead optimization in drug discovery
7.4.3.1.1 Biomarker discovery
7.4.3.1.2 Lead optimization in drug discovery
7.4.3.1.3 Toxicity testing
7.4.3.2 Promising (Quadrant 2) – Companion diagnostics for personalized medicine and nutrigenomics
7.4.3.2.1 Companion diagnostics for personalized medicine
7.4.3.2.2 Nutrigenomics
7.4.3.2.3 Agriculture
7.4.3.3 Challenges (Quadrant 3) – Environmental metabolomics
7.4.3.3.1 Environmental metabolomics
7.4.3.3.2 Functional genomics
8 METABOLOMICS MARKET SIZE, BY PRODUCT AND SERVICE
8.1 INTRODUCTION
TABLE 2 METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
8.2 METABOLOMICS INSTRUMENTS
TABLE 3 GLOBAL METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 4 METABOLOMICS INSTRUMENTS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 5 NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 ASIA PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 8 LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.1 SEPARATION TOOLS
TABLE 9 GLOBAL METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 NORTH AMERICA: METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 EUROPE: METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 ASIA PACIFIC: METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.2 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
8.2.2.1 Growing use of HPLC in high-growth applications to drive market growth
TABLE 15 GLOBAL HPLC MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 16 NORTH AMERICA: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 EUROPE: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 ASIA PACIFIC: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 LATIN AMERICA: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.3 GAS CHROMATOGRAPHY
8.2.3.1 Technological advancements in gas chromatography to drive adoption of GC in metabolome study
TABLE 20 GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 NORTH AMERICA: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 EUROPE: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 ASIA PACIFIC: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 LATIN AMERICA: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.4 ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY
8.2.4.1 Higher chromatographic efficiency and sensitivity of UPLC would drive market growth
TABLE 25 GLOBAL UPLC MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 EUROPE: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 ASIA PACIFIC: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 LATIN AMERICA: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.5 CAPILLARY ELECTROPHORESIS
8.2.5.1 CE is used in pathology/clinical laboratories worldwide due to the low cost of reagents, enhanced accuracy, and ease of operation
TABLE 30 GLOBAL CAPILLARY ELECTROPHORESIS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 EUROPE: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.6 DETECTION TOOLS
TABLE 35 GLOBAL METABOLOMICS DETECTION TOOLS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 GLOBAL METABOLOMICS DETECTION TOOLS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 EUROPE: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 ASIA PACIFIC: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 LATIN AMERICA: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.7 MASS SPECTROMETRY
8.2.7.1 Increasing use of mass spectrometry in cancer and genetic disease research is propelling its demand
TABLE 41 GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 EUROPE: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 ASIA PACIFIC: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 LATIN AMERICA: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.8 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
TABLE 46 GLOBAL NMR SPECTROSCOPY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 47 NORTH AMERICA: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 ASIA PACIFIC: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 LATIN AMERICA: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.9 SURFACE-BASED MASS ANALYSIS
8.2.9.1 Applicability of surface-based mass analysis technology in a wide range of samples would drive its growth
TABLE 51 GLOBAL SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 52 NORTH AMERICA: SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 53 EUROPE: SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 54 ASIA PACIFIC: SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 METABOLOMICS BIOINFORMATICS TOOLS & SERVICES
TABLE 55 GLOBAL METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2019–2025 (USD MILLION)
TABLE 56 GLOBAL BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 57 NORTH AMERICA: BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.3.1 BIOINFORMATICS SERVICES
8.3.1.1 Bioinformatics services offer a simplified way to derive insights from metabolomics research
TABLE 58 GLOBAL BIOINFORMATICS SERVICES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
8.3.2 BIOINFORMATICS TOOLS & DATABASES
8.3.2.1 Application of bioinformatics tools & databases in translational research to fuel market growth
TABLE 59 GLOBAL BIOINFORMATICS TOOLS & DATABASE MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
9 METABOLOMICS MARKET SIZE, BY APPLICATION
9.1 INTRODUCTION
TABLE 60 METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.2 BIOMARKER DISCOVERY
TABLE 61 METABOLOMICS MARKET SIZE FOR BIOMARKER DISCOVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 62 NORTH AMERICA: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 63 EUROPE: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 64 ASIA PACIFIC: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 LATIN AMERICA: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
9.3 DRUG DISCOVERY
TABLE 66 METABOLOMICS MARKET SIZE FOR DRUG DISCOVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 67 NORTH AMERICA: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 EUROPE: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 69 ASIA PACIFIC: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 70 LATIN AMERICA: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
9.4 TOXICOLOGY TESTING
TABLE 71 METABOLOMICS MARKET SIZE FOR TOXICOLOGY TESTING, BY REGION, 2018–2025 (USD MILLION)
TABLE 72 NORTH AMERICA: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 73 EUROPE: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 74 ASIA PACIFIC: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 75 LATIN AMERICA: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
9.5 NUTRIGENOMICS
TABLE 76 METABOLOMICS MARKET SIZE FOR NUTRIGENOMICS, BY REGION, 2018–2025 (USD MILLION)
TABLE 77 NORTH AMERICA: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 EUROPE: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 79 ASIA PACIFIC: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 80 LATIN AMERICA: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
9.6 PERSONALIZED MEDICINE
TABLE 81 METABOLOMICS MARKET SIZE FOR PERSONALIZED MEDICINES, BY REGION, 2018–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: PERSONALIZED MEDICINES METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 EUROPE: PERSONALIZED MEDICINES METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 84 ASIA PACIFIC: PERSONALIZED MEDICINES METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
9.7 FUNCTIONAL GENOMICS
TABLE 85 METABOLOMICS MARKET SIZE FOR FUNCTIONAL GENOMICS, BY REGION, 2018–2025 (USD MILLION)
TABLE 86 NORTH AMERICA: FUNCTIONAL GENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 87 EUROPE: FUNCTIONAL GENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 88 ASIA PACIFIC: FUNCTIONAL GENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
9.8 OTHER APPLICATIONS
TABLE 89 METABOLOMICS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 90 NORTH AMERICA: OTHER APPLICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 91 EUROPE: OTHER APPLICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 92 ASIA PACIFIC: OTHER APPLICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
10 METABOLOMICS MARKET SIZE, BY INDICATION
10.1 INTRODUCTION
TABLE 93 METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
10.2 CANCER
TABLE 94 METABOLOMICS MARKET SIZE FOR CANCER, BY REGION, 2018–2025 (USD MILLION)
TABLE 95 NORTH AMERICA: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 96 EUROPE: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 97 ASIA PACIFIC: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 98 LATIN AMERICA: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY 2018–2025 (USD MILLION)
10.3 CARDIOVASCULAR DISORDERS
TABLE 99 METABOLOMICS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 100 NORTH AMERICA: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 101 EUROPE: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 102 ASIA PACIFIC: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 103 LATIN AMERICA: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
10.4 NEUROLOGICAL DISORDERS
TABLE 104 METABOLOMICS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 105 NORTH AMERICA: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 106 EUROPE: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 107 ASIA PACIFIC: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 108 LATIN AMERICA: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
10.5 METABOLIC DISORDERS
TABLE 109 METABOLOMICS MARKET SIZE FOR METABOLIC DISORDERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 110 NORTH AMERICA: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 EUROPE: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 112 ASIA PACIFIC: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 113 LATIN AMERICA: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
10.6 INBORN ERRORS OF METABOLISM
TABLE 114 METABOLOMICS MARKET SIZE FOR INBORN ERRORS OF METABOLISM, BY REGION, 2018–2025 (USD MILLION)
TABLE 115 NORTH AMERICA: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 116 EUROPE: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 117 ASIA PACIFIC: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 118 LATIN AMERICA: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
10.7 OTHERS
TABLE 119 METABOLOMICS MARKET SIZE FOR OTHER INDICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 120 NORTH AMERICA: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 121 EUROPE: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 122 ASIA PACIFIC: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 123 LATIN AMERICA: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
11 METABOLOMICS MARKET SIZE, BY END USER
11.1 INTRODUCTION
TABLE 124 METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
11.2 ACADEMIC RESEARCH INSTITUTES
TABLE 125 METABOLOMICS MARKET SIZE FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 126 NORTH AMERICA: METABOLOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 127 EUROPE: METABOLOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 128 ASIA PACIFIC: METABOLOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
11.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
TABLE 129 METABOLOMICS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 130 NORTH AMERICA: METABOLOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 131 EUROPE: METABOLOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 132 ASIA PACIFIC: METABOLOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
11.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
TABLE 133 METABOLOMICS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
11.5 OTHERS
TABLE 134 METABOLOMICS MARKET SIZE FOR OTHER END USER, BY REGION, 2018–2025 (USD MILLION)
12 GLOBAL METABOLOMICS MARKET SIZE, BY REGION
12.1 INTRODUCTION
FIGURE 18 GLOBAL METABOLOMICS MARKET: GEOGRAPHICAL SNAPSHOT
TABLE 135 GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
12.2 NORTH AMERICA
FIGURE 19 NORTH AMERICA: METABOLOMICS MARKET SNAPSHOT
TABLE 136 NORTH AMERICA: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 137 NORTH AMERICA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 138 NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 139 NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 NORTH AMERICA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 142 NORTH AMERICA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 143 NORTH AMERICA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 144 NORTH AMERICA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.2.1 US
12.2.1.1 Significant government and private investments in biotechnology research in the country to drive market growth
TABLE 145 US: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 146 US: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 US: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 US: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 149 US: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 150 US: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 151 US: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 152 US: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.2.2 CANADA
12.2.2.1 Growing metabolomics research centers in the country to support market growth
TABLE 153 CANADA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 154 CANADA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 155 CANADA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 156 CANADA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 157 CANADA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 158 CANADA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 159 CANADA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 160 CANADA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3 EUROPE
TABLE 161 EUROPE: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 162 EUROPE: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 163 EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 165 EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 166 EUROPE: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 167 EUROPE: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 168 EUROPE: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 169 EUROPE: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.1 UK
12.3.1.1 Increasing focus on cancer research in the UK is a key growth driver
TABLE 170 UK: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 171 UK: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 172 UK: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173 UK: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 UK: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 175 UK: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 176 UK: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 177 UK: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.2 GERMANY
12.3.2.1 Significant R&D in the country to drive market growth
TABLE 178 GERMANY: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 179 GERMANY: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 180 GERMANY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 181 GERMANY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 182 GERMANY: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 183 GERMANY: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 184 GERMANY: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 185 GERMANY: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.3 FRANCE
12.3.3.1 Increased investments in biomedical research are likely to fuel market growth
TABLE 186 FRANCE: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 187 FRANCE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 188 FRANCE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 189 FRANCE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 190 FRANCE: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 191 FRANCE: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 192 FRANCE: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 193 FRANCE: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.4 ITALY
12.3.4.1 Growth in nutrigenomics to drive market growth
TABLE 194 ITALY: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 195 ITALY: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 196 ITALY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 197 ITALY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 198 ITALY: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 199 ITALY: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 200 ITALY: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 201 ITALY: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.5 SPAIN
12.3.5.1 Growth in the food, agriculture, and biotechnology industries will drive market growth
TABLE 202 SPAIN: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 203 SPAIN: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204 SPAIN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 205 SPAIN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 206 SPAIN: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 207 SPAIN: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 208 SPAIN: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 209 SPAIN: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.6 REST OF EUROPE (ROE)
TABLE 210 REST OF EUROPE: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 211 ROE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 212 ROE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 213 ROE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 214 ROE: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 215 ROE: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 216 ROE: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 217 ROE: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 20 ASIA PACIFIC: METABOLOMICS MARKET SNAPSHOT
TABLE 218 ASIA PACIFIC: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 219 ASIA PACIFIC: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 220 ASIA PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 221 ASIA PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 222 ASIA PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223 ASIA PACIFIC: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 ASIA PACIFIC: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 225 ASIA PACIFIC: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 226 ASIA PACIFIC: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.4.1 CHINA
12.4.1.1 International alliances for R&D activities are driving the market
TABLE 227 CHINA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 228 CHINA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 229 CHINA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 230 CHINA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 231 CHINA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 232 CHINA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 233 CHINA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 234 CHINA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.4.2 JAPAN
12.4.2.1 Increasing focus on personalized diagnostics products to support market growth in Japan
TABLE 235 JAPAN: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 236 JAPAN: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 237 JAPAN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 238 JAPAN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 239 JAPAN: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 240 JAPAN: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 241 JAPAN: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 242 JAPAN: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.4.3 INDIA
12.4.3.1 Initiatives to increase the adoption of metabolomics in India to drive the market
TABLE 243 INDIA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 244 INDIA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 245 INDIA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 246 INDIA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 247 INDIA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 248 INDIA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 249 INDIA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 250 INDIA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.4.4 REST OF APAC
TABLE 251 ROAPAC: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 252 ROAPAC: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 253 ROAPAC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 254 ROAPAC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 255 ROAPAC: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 256 ROAPAC: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 257 ROAPAC: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 258 ROAPAC: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.5 LATIN AMERICA
TABLE 259 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 260 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 261 LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 262 LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 263 LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 264 LATIN AMERICA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 265 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 266 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 267 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.5.1 BRAZIL
12.5.1.1 Growing biologics sector in the country to drive the market
TABLE 268 BRAZIL: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 269 BRAZIL: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 270 BRAZIL: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 271 BRAZIL: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 272 BRAZIL: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 273 BRAZIL: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 274 BRAZIL: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 275 BRAZIL: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.5.2 MEXICO
12.5.2.1 Favorable business environment for market players to support market growth
TABLE 276 MEXICO: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 277 MEXICO: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 278 MEXICO: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 279 MEXICO: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 280 MEXICO: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 281 MEXICO: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 282 MEXICO: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 283 MEXICO: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.5.3 REST OF LATIN AMERICA
TABLE 284 ROLA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 285 ROLA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 286 ROLA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 287 ROLA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 288 ROLA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 289 ROLA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 290 ROLA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 291 ROLA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.6 MIDDLE EAST & AFRICA
TABLE 292 MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 293 MIDDLE EAST & AFRICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 294 MIDDLE EAST & AFRICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 295 MIDDLE EAST & AFRICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 296 MIDDLE EAST & AFRICA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 297 MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 298 MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 299 MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 MARKET SHARE ANALYSIS (2019)
FIGURE 21 GLOBAL METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2019
13.3 KEY MARKET DEVELOPMENTS
13.3.1 PRODUCT LAUNCHES
13.3.2 ACQUISITIONS
13.3.3 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
13.3.4 EXPANSIONS
14 COMPANY EVALUATION MATRIX
14.1 OVERVIEW
14.2 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2019)
14.2.1 STARS
14.2.2 EMERGING LEADERS
14.2.3 PERVASIVE
14.2.4 PARTICIPANTS
FIGURE 22 METABOLOMICS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
14.3 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.3.1 THERMO FISHER SCIENTIFIC INC.
FIGURE 23 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
14.3.2 AGILENT TECHNOLOGIES, INC.
FIGURE 24 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
14.3.3 WATERS CORPORATION
FIGURE 25 WATERS CORPORATION: COMPANY SNAPSHOT (2019)
14.3.4 DANAHER CORPORATION
FIGURE 26 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
14.3.5 SHIMADZU CORPORATION
FIGURE 27 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2019)
14.3.6 BIO-RAD LABORATORIES, INC.
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
14.3.7 BRUKER CORPORATION
FIGURE 29 BRUKER CORPORATION: COMPANY SNAPSHOT (2019)
14.3.8 PERKINELMER, INC.
FIGURE 30 PERKINELMER, INC.: COMPANY SNAPSHOT (2019)
14.3.9 MERCK KGAA
FIGURE 31 MERCK KGAA: COMPANY SNAPSHOT (2019)
14.3.10 GE HEALTHCARE
FIGURE 32 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
14.3.11 HITACHI HIGH-TECHNOLOGIES CORPORATION
FIGURE 33 HITACHI HIGH-TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT (2019)
14.3.12 HUMAN METABOLOME TECHNOLOGIES, INC.
14.3.13 LECO CORPORATION
14.3.14 METABOLON, INC.
14.3.15 DANI INSTRUMENTS
14.3.16 SCION INSTRUMENTS
14.3.17 GL SCIENCES
14.3.18 SRI INSTRUMENTS
14.3.20 KORE TECHNOLOGY
14.3.21 JASCO, INC.
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGE STORE
15.3 AVAILABLE CUSTOMIZATIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 GLOBAL METABOLOMICS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: METABOLOMICS MARKET
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
2.1.4 DATA TRIANGULATION
FIGURE 3 DATA TRIANGULATION METHODOLOGY
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
FIGURE 5 METABOLOMICS MARKET SIZE (USD MILLION)
FIGURE 6 METABOLOMICS MARKET: GROWTH RATE OF TOP COMPANIES (2018?2019)
FIGURE 7 METABOLOMICS MARKET: FINAL CAGR PROJECTIONS (2020?2025)
FIGURE 8 METABOLOMICS MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
2.3 INDUSTRY INSIGHTS
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 9 METABOLOMICS MARKET SHARE, BY PRODUCT & SERVICE, 2019 VS. 2025 (USD MILLION)
FIGURE 10 METABOLOMICS MARKET SHARE, BY APPLICATION, 2019
FIGURE 11 METABOLOMICS MARKET SIZE, BY INDICATION, 2020 VS. 2025
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE METABOLOMICS MARKET
4 PREMIUM INSIGHTS
4.1 METABOLOMICS MARKET OVERVIEW
FIGURE 13 INCREASING PHARMACEUTICALS R&D ACTIVITIES AND GROWING DEMAND FOR PERSONALIZED MEDICINE WILL FAVOR MARKET GROWTH
4.2 ASIA PACIFIC: METABOLOMICS MARKET SHARE, BY PRODUCT AND SERVICE AND BY COUNTRY (2019)
FIGURE 14 METABOLOMICS INSTRUMENTS SEGMENT ACCOUNTED FOR LARGER SHARE OF ASIA PACIFIC MARKET IN 2019
4.3 METABOLOMICS MARKET SIZE, BY DETECTION TOOLS
FIGURE 15 MASS SPECTROMETRY (MS) SEGMENT WILL CONTINUE TO DOMINATE THE MARKET
4.4 METABOLOMICS MARKET SHARE, BY SEPARATION TOOLS, 2020 VS. 2025
FIGURE 16 HPLC HOLDS THE LARGEST SHARE OF THE MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 METABOLOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 KEY MARKET DRIVERS
5.2.1.1 Availability of government and private funding for metabolomics research
5.2.1.2 Increasing pharmaceutical and biotech R&D expenditure
5.2.1.3 Growing demand for personalized medicine
5.2.2 KEY MARKET RESTRAINTS
5.2.2.1 Issues related to data examination and processing
5.2.2.2 High cost of tools and instruments
5.2.3 KEY MARKET OPPORTUNITIES
5.2.3.1 Biomarker development
5.2.3.2 Lucrative opportunities in emerging markets
5.2.4 KEY MARKET CHALLENGES
5.2.4.1 Complexity and diversity of biological samples
5.2.4.2 Dearth of skilled researchers
5.3 IMPACT OF COVID-19 ON GROWTH OF METABOLOMICS MARKET
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES
6.2.2 TIE-UPS BETWEEN INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS
6.3 REGULATORY ANALYSIS
TABLE 1 REGULATORY STANDARD/APPROVAL REQUIRED FOR METABOLOMICS PRODUCTS, BY COUNTRY/REGION
7 TECHNOLOGY INVESTMENT POTENTIAL
7.1 INTRODUCTION
7.2 INVESTMENT CLIENT NETWORKS
7.3 FUNDING BODIES/INITIATIVES
7.4 ANALYSIS OF POTENTIAL AREAS FOR TECHNOLOGY INVESTMENT USING STRATEGIC EVALUATION
7.4.1 PARAMETERS CONSIDERED FOR EMERGING OPPORTUNITY EVALUATION
7.4.1.1 Level of attractiveness
7.4.1.2 Probability of success
7.4.2 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS
7.4.3 DESCRIPTION OF OPPORTUNITIES
7.4.3.1 Viable (Quadrant 1) – Biomarker discovery and lead optimization in drug discovery
7.4.3.1.1 Biomarker discovery
7.4.3.1.2 Lead optimization in drug discovery
7.4.3.1.3 Toxicity testing
7.4.3.2 Promising (Quadrant 2) – Companion diagnostics for personalized medicine and nutrigenomics
7.4.3.2.1 Companion diagnostics for personalized medicine
7.4.3.2.2 Nutrigenomics
7.4.3.2.3 Agriculture
7.4.3.3 Challenges (Quadrant 3) – Environmental metabolomics
7.4.3.3.1 Environmental metabolomics
7.4.3.3.2 Functional genomics
8 METABOLOMICS MARKET SIZE, BY PRODUCT AND SERVICE
8.1 INTRODUCTION
TABLE 2 METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
8.2 METABOLOMICS INSTRUMENTS
TABLE 3 GLOBAL METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 4 METABOLOMICS INSTRUMENTS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 5 NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 ASIA PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 8 LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.1 SEPARATION TOOLS
TABLE 9 GLOBAL METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 NORTH AMERICA: METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 EUROPE: METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 ASIA PACIFIC: METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.2 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
8.2.2.1 Growing use of HPLC in high-growth applications to drive market growth
TABLE 15 GLOBAL HPLC MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 16 NORTH AMERICA: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 EUROPE: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 ASIA PACIFIC: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 LATIN AMERICA: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.3 GAS CHROMATOGRAPHY
8.2.3.1 Technological advancements in gas chromatography to drive adoption of GC in metabolome study
TABLE 20 GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 NORTH AMERICA: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 EUROPE: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 ASIA PACIFIC: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 LATIN AMERICA: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.4 ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY
8.2.4.1 Higher chromatographic efficiency and sensitivity of UPLC would drive market growth
TABLE 25 GLOBAL UPLC MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 EUROPE: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 ASIA PACIFIC: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 LATIN AMERICA: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.5 CAPILLARY ELECTROPHORESIS
8.2.5.1 CE is used in pathology/clinical laboratories worldwide due to the low cost of reagents, enhanced accuracy, and ease of operation
TABLE 30 GLOBAL CAPILLARY ELECTROPHORESIS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 EUROPE: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.6 DETECTION TOOLS
TABLE 35 GLOBAL METABOLOMICS DETECTION TOOLS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 GLOBAL METABOLOMICS DETECTION TOOLS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 EUROPE: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 ASIA PACIFIC: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 LATIN AMERICA: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.7 MASS SPECTROMETRY
8.2.7.1 Increasing use of mass spectrometry in cancer and genetic disease research is propelling its demand
TABLE 41 GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 EUROPE: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 ASIA PACIFIC: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 LATIN AMERICA: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.8 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
TABLE 46 GLOBAL NMR SPECTROSCOPY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 47 NORTH AMERICA: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 ASIA PACIFIC: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 LATIN AMERICA: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.2.9 SURFACE-BASED MASS ANALYSIS
8.2.9.1 Applicability of surface-based mass analysis technology in a wide range of samples would drive its growth
TABLE 51 GLOBAL SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 52 NORTH AMERICA: SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 53 EUROPE: SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 54 ASIA PACIFIC: SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 METABOLOMICS BIOINFORMATICS TOOLS & SERVICES
TABLE 55 GLOBAL METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2019–2025 (USD MILLION)
TABLE 56 GLOBAL BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 57 NORTH AMERICA: BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
8.3.1 BIOINFORMATICS SERVICES
8.3.1.1 Bioinformatics services offer a simplified way to derive insights from metabolomics research
TABLE 58 GLOBAL BIOINFORMATICS SERVICES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
8.3.2 BIOINFORMATICS TOOLS & DATABASES
8.3.2.1 Application of bioinformatics tools & databases in translational research to fuel market growth
TABLE 59 GLOBAL BIOINFORMATICS TOOLS & DATABASE MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
9 METABOLOMICS MARKET SIZE, BY APPLICATION
9.1 INTRODUCTION
TABLE 60 METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.2 BIOMARKER DISCOVERY
TABLE 61 METABOLOMICS MARKET SIZE FOR BIOMARKER DISCOVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 62 NORTH AMERICA: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 63 EUROPE: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 64 ASIA PACIFIC: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 LATIN AMERICA: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
9.3 DRUG DISCOVERY
TABLE 66 METABOLOMICS MARKET SIZE FOR DRUG DISCOVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 67 NORTH AMERICA: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 EUROPE: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 69 ASIA PACIFIC: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 70 LATIN AMERICA: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
9.4 TOXICOLOGY TESTING
TABLE 71 METABOLOMICS MARKET SIZE FOR TOXICOLOGY TESTING, BY REGION, 2018–2025 (USD MILLION)
TABLE 72 NORTH AMERICA: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 73 EUROPE: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 74 ASIA PACIFIC: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 75 LATIN AMERICA: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
9.5 NUTRIGENOMICS
TABLE 76 METABOLOMICS MARKET SIZE FOR NUTRIGENOMICS, BY REGION, 2018–2025 (USD MILLION)
TABLE 77 NORTH AMERICA: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 EUROPE: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 79 ASIA PACIFIC: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 80 LATIN AMERICA: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
9.6 PERSONALIZED MEDICINE
TABLE 81 METABOLOMICS MARKET SIZE FOR PERSONALIZED MEDICINES, BY REGION, 2018–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: PERSONALIZED MEDICINES METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 EUROPE: PERSONALIZED MEDICINES METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 84 ASIA PACIFIC: PERSONALIZED MEDICINES METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
9.7 FUNCTIONAL GENOMICS
TABLE 85 METABOLOMICS MARKET SIZE FOR FUNCTIONAL GENOMICS, BY REGION, 2018–2025 (USD MILLION)
TABLE 86 NORTH AMERICA: FUNCTIONAL GENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 87 EUROPE: FUNCTIONAL GENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 88 ASIA PACIFIC: FUNCTIONAL GENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
9.8 OTHER APPLICATIONS
TABLE 89 METABOLOMICS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 90 NORTH AMERICA: OTHER APPLICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 91 EUROPE: OTHER APPLICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 92 ASIA PACIFIC: OTHER APPLICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
10 METABOLOMICS MARKET SIZE, BY INDICATION
10.1 INTRODUCTION
TABLE 93 METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
10.2 CANCER
TABLE 94 METABOLOMICS MARKET SIZE FOR CANCER, BY REGION, 2018–2025 (USD MILLION)
TABLE 95 NORTH AMERICA: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 96 EUROPE: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 97 ASIA PACIFIC: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 98 LATIN AMERICA: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY 2018–2025 (USD MILLION)
10.3 CARDIOVASCULAR DISORDERS
TABLE 99 METABOLOMICS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 100 NORTH AMERICA: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 101 EUROPE: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 102 ASIA PACIFIC: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 103 LATIN AMERICA: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
10.4 NEUROLOGICAL DISORDERS
TABLE 104 METABOLOMICS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 105 NORTH AMERICA: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 106 EUROPE: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 107 ASIA PACIFIC: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 108 LATIN AMERICA: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
10.5 METABOLIC DISORDERS
TABLE 109 METABOLOMICS MARKET SIZE FOR METABOLIC DISORDERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 110 NORTH AMERICA: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 EUROPE: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 112 ASIA PACIFIC: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 113 LATIN AMERICA: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
10.6 INBORN ERRORS OF METABOLISM
TABLE 114 METABOLOMICS MARKET SIZE FOR INBORN ERRORS OF METABOLISM, BY REGION, 2018–2025 (USD MILLION)
TABLE 115 NORTH AMERICA: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 116 EUROPE: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 117 ASIA PACIFIC: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 118 LATIN AMERICA: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
10.7 OTHERS
TABLE 119 METABOLOMICS MARKET SIZE FOR OTHER INDICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 120 NORTH AMERICA: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 121 EUROPE: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 122 ASIA PACIFIC: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 123 LATIN AMERICA: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
11 METABOLOMICS MARKET SIZE, BY END USER
11.1 INTRODUCTION
TABLE 124 METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
11.2 ACADEMIC RESEARCH INSTITUTES
TABLE 125 METABOLOMICS MARKET SIZE FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 126 NORTH AMERICA: METABOLOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 127 EUROPE: METABOLOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 128 ASIA PACIFIC: METABOLOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
11.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
TABLE 129 METABOLOMICS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 130 NORTH AMERICA: METABOLOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 131 EUROPE: METABOLOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 132 ASIA PACIFIC: METABOLOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
11.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
TABLE 133 METABOLOMICS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
11.5 OTHERS
TABLE 134 METABOLOMICS MARKET SIZE FOR OTHER END USER, BY REGION, 2018–2025 (USD MILLION)
12 GLOBAL METABOLOMICS MARKET SIZE, BY REGION
12.1 INTRODUCTION
FIGURE 18 GLOBAL METABOLOMICS MARKET: GEOGRAPHICAL SNAPSHOT
TABLE 135 GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
12.2 NORTH AMERICA
FIGURE 19 NORTH AMERICA: METABOLOMICS MARKET SNAPSHOT
TABLE 136 NORTH AMERICA: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 137 NORTH AMERICA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 138 NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 139 NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 NORTH AMERICA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 142 NORTH AMERICA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 143 NORTH AMERICA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 144 NORTH AMERICA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.2.1 US
12.2.1.1 Significant government and private investments in biotechnology research in the country to drive market growth
TABLE 145 US: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 146 US: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 US: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 US: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 149 US: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 150 US: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 151 US: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 152 US: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.2.2 CANADA
12.2.2.1 Growing metabolomics research centers in the country to support market growth
TABLE 153 CANADA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 154 CANADA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 155 CANADA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 156 CANADA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 157 CANADA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 158 CANADA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 159 CANADA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 160 CANADA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3 EUROPE
TABLE 161 EUROPE: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 162 EUROPE: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 163 EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 165 EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 166 EUROPE: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 167 EUROPE: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 168 EUROPE: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 169 EUROPE: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.1 UK
12.3.1.1 Increasing focus on cancer research in the UK is a key growth driver
TABLE 170 UK: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 171 UK: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 172 UK: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173 UK: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 UK: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 175 UK: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 176 UK: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 177 UK: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.2 GERMANY
12.3.2.1 Significant R&D in the country to drive market growth
TABLE 178 GERMANY: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 179 GERMANY: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 180 GERMANY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 181 GERMANY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 182 GERMANY: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 183 GERMANY: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 184 GERMANY: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 185 GERMANY: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.3 FRANCE
12.3.3.1 Increased investments in biomedical research are likely to fuel market growth
TABLE 186 FRANCE: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 187 FRANCE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 188 FRANCE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 189 FRANCE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 190 FRANCE: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 191 FRANCE: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 192 FRANCE: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 193 FRANCE: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.4 ITALY
12.3.4.1 Growth in nutrigenomics to drive market growth
TABLE 194 ITALY: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 195 ITALY: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 196 ITALY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 197 ITALY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 198 ITALY: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 199 ITALY: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 200 ITALY: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 201 ITALY: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.5 SPAIN
12.3.5.1 Growth in the food, agriculture, and biotechnology industries will drive market growth
TABLE 202 SPAIN: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 203 SPAIN: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204 SPAIN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 205 SPAIN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 206 SPAIN: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 207 SPAIN: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 208 SPAIN: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 209 SPAIN: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.3.6 REST OF EUROPE (ROE)
TABLE 210 REST OF EUROPE: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 211 ROE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 212 ROE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 213 ROE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 214 ROE: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 215 ROE: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 216 ROE: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 217 ROE: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 20 ASIA PACIFIC: METABOLOMICS MARKET SNAPSHOT
TABLE 218 ASIA PACIFIC: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 219 ASIA PACIFIC: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 220 ASIA PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 221 ASIA PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 222 ASIA PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223 ASIA PACIFIC: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 ASIA PACIFIC: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 225 ASIA PACIFIC: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 226 ASIA PACIFIC: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.4.1 CHINA
12.4.1.1 International alliances for R&D activities are driving the market
TABLE 227 CHINA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 228 CHINA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 229 CHINA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 230 CHINA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 231 CHINA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 232 CHINA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 233 CHINA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 234 CHINA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.4.2 JAPAN
12.4.2.1 Increasing focus on personalized diagnostics products to support market growth in Japan
TABLE 235 JAPAN: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 236 JAPAN: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 237 JAPAN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 238 JAPAN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 239 JAPAN: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 240 JAPAN: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 241 JAPAN: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 242 JAPAN: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.4.3 INDIA
12.4.3.1 Initiatives to increase the adoption of metabolomics in India to drive the market
TABLE 243 INDIA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 244 INDIA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 245 INDIA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 246 INDIA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 247 INDIA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 248 INDIA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 249 INDIA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 250 INDIA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.4.4 REST OF APAC
TABLE 251 ROAPAC: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 252 ROAPAC: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 253 ROAPAC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 254 ROAPAC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 255 ROAPAC: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 256 ROAPAC: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 257 ROAPAC: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 258 ROAPAC: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.5 LATIN AMERICA
TABLE 259 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 260 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 261 LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 262 LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 263 LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 264 LATIN AMERICA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 265 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 266 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 267 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.5.1 BRAZIL
12.5.1.1 Growing biologics sector in the country to drive the market
TABLE 268 BRAZIL: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 269 BRAZIL: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 270 BRAZIL: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 271 BRAZIL: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 272 BRAZIL: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 273 BRAZIL: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 274 BRAZIL: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 275 BRAZIL: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.5.2 MEXICO
12.5.2.1 Favorable business environment for market players to support market growth
TABLE 276 MEXICO: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 277 MEXICO: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 278 MEXICO: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 279 MEXICO: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 280 MEXICO: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 281 MEXICO: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 282 MEXICO: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 283 MEXICO: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.5.3 REST OF LATIN AMERICA
TABLE 284 ROLA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 285 ROLA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 286 ROLA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 287 ROLA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 288 ROLA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 289 ROLA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 290 ROLA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 291 ROLA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
12.6 MIDDLE EAST & AFRICA
TABLE 292 MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 293 MIDDLE EAST & AFRICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 294 MIDDLE EAST & AFRICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 295 MIDDLE EAST & AFRICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 296 MIDDLE EAST & AFRICA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 297 MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 298 MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 299 MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 MARKET SHARE ANALYSIS (2019)
FIGURE 21 GLOBAL METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2019
13.3 KEY MARKET DEVELOPMENTS
13.3.1 PRODUCT LAUNCHES
13.3.2 ACQUISITIONS
13.3.3 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
13.3.4 EXPANSIONS
14 COMPANY EVALUATION MATRIX
14.1 OVERVIEW
14.2 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2019)
14.2.1 STARS
14.2.2 EMERGING LEADERS
14.2.3 PERVASIVE
14.2.4 PARTICIPANTS
FIGURE 22 METABOLOMICS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
14.3 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.3.1 THERMO FISHER SCIENTIFIC INC.
FIGURE 23 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
14.3.2 AGILENT TECHNOLOGIES, INC.
FIGURE 24 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
14.3.3 WATERS CORPORATION
FIGURE 25 WATERS CORPORATION: COMPANY SNAPSHOT (2019)
14.3.4 DANAHER CORPORATION
FIGURE 26 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
14.3.5 SHIMADZU CORPORATION
FIGURE 27 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2019)
14.3.6 BIO-RAD LABORATORIES, INC.
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
14.3.7 BRUKER CORPORATION
FIGURE 29 BRUKER CORPORATION: COMPANY SNAPSHOT (2019)
14.3.8 PERKINELMER, INC.
FIGURE 30 PERKINELMER, INC.: COMPANY SNAPSHOT (2019)
14.3.9 MERCK KGAA
FIGURE 31 MERCK KGAA: COMPANY SNAPSHOT (2019)
14.3.10 GE HEALTHCARE
FIGURE 32 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
14.3.11 HITACHI HIGH-TECHNOLOGIES CORPORATION
FIGURE 33 HITACHI HIGH-TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT (2019)
14.3.12 HUMAN METABOLOME TECHNOLOGIES, INC.
14.3.13 LECO CORPORATION
14.3.14 METABOLON, INC.
14.3.15 DANI INSTRUMENTS
14.3.16 SCION INSTRUMENTS
14.3.17 GL SCIENCES
14.3.18 SRI INSTRUMENTS
14.3.20 KORE TECHNOLOGY
14.3.21 JASCO, INC.
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGE STORE
15.3 AVAILABLE CUSTOMIZATIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
